Stocks and securities in focus
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y ▼ | 5y |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | -0.090% | -1.032% | -0.455% | 107.681% | 32.633% | 343.368% | 580.961% |
| Voyager Therapeutics Inc | -4.190% | -11.968% | -15.263% | 1.329% | -8.868% | 90.157% | - |
| Merck & Co. Inc. | -0.340% | 0.000% | 5.188% | 12.214% | 19.391% | 81.903% | 80.313% |
| Zoetis Inc. A | -1.630% | -5.156% | -8.411% | -9.563% | -19.100% | 2.816% | 63.102% |
| Sartorius AG ST | 0.240% | -20.151% | -22.344% | -33.228% | -19.697% | -49.222% | 53.069% |
| Immuron | -0.910% | -14.844% | -6.034% | 21.788% | 30.539% | -50.679% | - |
| Larimar Therapeutics Inc. | -2.500% | 2.344% | -17.610% | 53.037% | 54.481% | -54.828% | - |
| ProQR Therapeutics N.V. | 1.020% | -3.022% | -9.833% | 3.112% | 14.749% | -58.920% | - |
| Deciphera Pharmaceuticals | -3.650% | -7.042% | -2.798% | -5.138% | -10.174% | -64.894% | - |
| Vanda Pharmaceuticals | -2.140% | 17.000% | 33.714% | -17.895% | 20.619% | -65.075% | - |
| Adaptimmune Therapeutics PLC ADR | -2.960% | -30.165% | -36.940% | -33.465% | 35.200% | -79.490% | - |
| Vaxart Inc. | -0.370% | -18.135% | -26.306% | 25.040% | 53.220% | -82.323% | - |
| Enlivex Therapeutics Ltd. | -2.100% | -61.326% | -61.111% | -46.970% | -37.500% | -84.358% | - |
| Alterity Therapeutics Ltd. ADR | - | -0.613% | 24.615% | -30.172% | -21.359% | -85.000% | -89.270% |
| Fate Therapeutics Inc. | -1.880% | -14.595% | -26.874% | -16.608% | 33.296% | -93.009% | - |
| Jaguar Health Inc. | -2.880% | 67.068% | 160.000% | 112.788% | 10.199% | -99.931% | - |
| Viracta Therapeutics Inc. | 4.140% | - | - | - | - | - | - |
| Applied Therapeutics Inc | -8.860% | - | - | - | - | - | - |
| Inotiv Inc. | -2.350% | -28.710% | -46.098% | 4.739% | 34.756% | - | - |
| Novo Nordisk A/S | -0.080% | - | - | - | - | - | - |